MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Examining Disparities and Device Usage in Outpatient Telemedicine Visits Amongst Movement Disorders Patients

V. Palakuzhy, B. Ouyang, G. Stebbins, C. Goetz, M. Afshari (Chicago, USA)

Meeting: 2025 International Congress

Keywords: Interventions

Category: Telemedicine

Objective: To characterize trends in device usage (mobile-device vs. personal computer (PC)) across demographic factors for video-based telemedicine visits in an urban tertiary Movement Disorders clinic in the U.S.

Background: The rise of telemedicine during the COVID-19 pandemic has improved healthcare access, but data on device usage and disparities in telemedicine access remains limited. We hypothesized high mobile-device usage and ubiquity of telemedicine utilization across diverse demographic groups.

Method: We conducted a retrospective chart review of all televisits with Movement Disorders neurologists at Rush University from March 2020 to March 2023, analyzing visit-specific data embedded within the electronic medical record.  We analyzed variations in device usage patterns across different age groups (<60, ≥60), sex, race, and socioeconomic status (zip code median income). Televisits were categorized into mobile (smartphones and tablets) or PC-only. Chi-square tests examined the device usage distribution, with effect sizes calculated to assess the strength of differences. Logistic regression analyzed the odds of mobile-only usage.

Results: We identified 2,181 unique patient televisits. 87.8% of televisits were accessed with mobile-devices.  The mean age of mobile users was slightly lower at 62.1 vs. 64.9 years in PC-users (p=0.02).  The Chi-Square analysis revealed statistically significant but clinically insignificant results due to small effect sizes (both 0.07): younger patients (<20) showed the highest mobile use (p=0.03) and the lowest income quintile had 100% mobile usage while the highest quintile had the lowest (p=0.03). Logistic regression revealed no significant predictors of mobile usage.

Conclusion: Mobile-device use for telemedicine in Movement Disorders is widespread across all demographics. These findings emphasize the role smartphones play in facilitating access to telemedicine, suggesting that enhancing mobile-based telemedicine applications could improve healthcare equity particularly for vulnerable populations.

Presented at 2024 PSG Annual Meeting on December 5th, 2024.

Accepted for 2025 AAN Annual Meeting on April 6th, 2025.

To cite this abstract in AMA style:

V. Palakuzhy, B. Ouyang, G. Stebbins, C. Goetz, M. Afshari. Examining Disparities and Device Usage in Outpatient Telemedicine Visits Amongst Movement Disorders Patients [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/examining-disparities-and-device-usage-in-outpatient-telemedicine-visits-amongst-movement-disorders-patients/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/examining-disparities-and-device-usage-in-outpatient-telemedicine-visits-amongst-movement-disorders-patients/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley